Catalog Number HT076080 |
Device Problem
Contamination (1120)
|
Patient Problem
Unspecified Infection (1930)
|
Event Date 11/17/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Analysis-report from third party was received and will be further investigated.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
It was reported to gore that patient underwent endovascular treatment for a right-left crossed femoro-femoral bypass with a gore® propaten® vascular graft - thin-walled removable ringed.It was stated that the prosthesis was implanted on (b)(6) 2020 in order to treat an acute ischemia of the left lower limb following the treatment of a type a aortic dissection by open surgery.It was reported that on (b)(6) 2020, after about 2 months, the distal part of the prosthesis was explanted due to a rupture of the distal anastomosis (case (b)(4)).It was stated that 6 days later, the rest of the prosthesis was explanted due to the infection.
|
|
Manufacturer Narrative
|
H6 evaluation codes investigation findings 213 refers to the phr-review: a review of the manufacturing records indicated the released portion of the lot met all pre-release specifications.Analysis-report from third party was received and will be further investigated.
|
|
Manufacturer Narrative
|
Explant investigation: the device was returned to geprovas for investigation.Submitted in formalin was one gore® propaten® vascular graft fragment.The scope and results of the investigation were summarized, and a report was submitted to w.L.Gore & associates.An explant scientist at w.L.Gore & associates reviewed the report and performed in person on-site evaluation of the specimen.Explant scientist observations: the graft fragment was reported to measure 120 mm in length with both ends transected.The ablumen was encased in light tan/tan tissue with multifocal deposits yellow (presumed adipose) tissue.Blue alignment marks were faintly visible on inspection.The lumen of extremity a was occupied with gelatinous brown tissue.Extremity b was ligated with multifilament blue-green suture in a continuous running pattern.The graft fragment was not patent.Reason: based on the explant scientist¿s review of the geprovas report, no additional analysis is requested.The reported reason for removal was infection with no accusation of infection being device related from the physician.The origin of infection cannot be determined with the information provided nor via the analyses available.
|
|
Manufacturer Narrative
|
Product history review: a review of the sterilization records indicated the lot met all pre-release specifications.
|
|
Manufacturer Narrative
|
Added to section c1: suspect products: name: cbas® heparin surface.Manufacturer/compounder: w.L.Gore & associates, inc.Lot number: 6670923pp002.
|
|
Search Alerts/Recalls
|